Abstract
Peptic ulcer disease (PUD) can lead to life-threatening bleeding. Endoscopy is a primary intervention used to locate the site of bleeding and maintain hemostasis. When considering multiple risk factors to operative intervention or failed initial endoscopic procedure in patients, the preferred treatment for acute gastrointestinal bleeding remains endovascular coiling to embolize the culprit's vessel. We report a case of a 57-year-old female who presents with melena secondary to gastric ulcer not amenable to endoscopic interventions. Various embolization techniques are available demanding clinicians' attention towards their role in managing ulcer bleeds and their impact on the controlling bleeds.
Keywords: peptic ulcer bleed, tae, transarterial coil embolization, angiographic embolization, pud
Introduction
Peptic ulcer disease (PUD) comprises duodenal and gastric ulcers, where gastric ulcers being more common due to a greater incidence [1]. Incidence depends on various risk factors and co-morbidities, including often overlooked concomitant use of blood thinners and a history of chronic analgesic intake. Management plan algorithm starts from proton pump inhibitors (PPIs), followed by endoscopy, angiography, embolization, or surgery, based on clinical severity. We report a case of a 57-year-old female on chronic anticoagulation for antiphospholipid syndrome who presented with a massive duodenal ulcer refractory to endoscopic measures. The patient was initially resuscitated and treated medically, followed by endoscopic clipping, which failed to provide desired results. Ultimately, she was managed with coil embolization by vascular interventional radiology. We review the effectiveness of the embolization technique using endovascular coiling, managing ulcer bleeds, and its impact on vasculature's anatomical significance [2].
Case presentation
A 57-year-old female with multiple melanic bowel movements for one day presented in the emergency department (ED). Her past medical history was significant for systemic lupus erythematosus (SLE), antiphospholipid syndrome, lacunar infarct, hypertension, and osteoarthritis of both knees’ status post arthroplasty. She denied any abdominal pain, nausea, vomiting, or hematemesis. Due to the subtherapeutic international normalized ratio (INR), low molecular weight heparin (LMWH) was added to her anticoagulation regimen for three days. She was also taking meloxicam chronically for her arthritis and prednisone for SLE. The previous history of gastrointestinal bleed or ulcers was negative. Her basic labs revealed hemoglobin of 5 g/dL, INR 2.5, and platelet count within normal limits. While in the ED, she had ongoing melena but was hemodynamically stable. Her warfarin and LMWH were held, and her INR was reversed with fresh frozen plasma. She also received multiple packed red blood cells for a goal of hemoglobin of 7-9 g/dL. Emergent endoscopy revealed a clot in the duodenum extending into the antrum overlying a large 12 mm gastric ulcer with a visible vessel within the pyloric channel extending into the proximal bulb not amenable to endoscopic clipping (Figure 1).
Figure 1. Gastric ulcer within pyloric channel extending into proximal bulb (yellow arrow).
Interventional radiology was consulted, and on the pancreaticoduodenal arteriogram, active extravasation was demonstrated (Figure 2).
Figure 2. Active extravasation of dye due to the culprit vessel erosion by the ulcer (yellow arrow).
Following coil and surgifoam embolization of the gastroduodenal artery (GDA), the post-embolization arteriogram revealed occlusion of this vessel; and the patient underwent successful embolization of the GDA and main pancreaticoduodenal artery supplying the ulcer. She was later started back on her anticoagulation with heparin bridging and discharged with outpatient follow-up.
Discussion
Endoscopic hemostasis is the gold standard and first-line treatment for bleeding peptic ulcers with a relatively low failure rate (8%-25%), followed by surgical intervention despite no significant change in the rate of mortality [3]. A bridge between endoscopic and surgical intervention is endovascular coiling or transcatheter arterial embolization (TAE). This is an effective and safe method to control the bleeds or rebleeds after the failure of conventional endoscopic interventions with low mortality in patients with coagulation dyscrasias, antiplatelet therapies, liver dysfunction, and on chronic anticoagulation [4]. The typical indications for TAE include massive bleeding (transfusion requirement ≥ four units of blood per 24 h), hemodynamic instability secondary to blood loss, failure to conservative medical therapy [volume replacement, antacids, H2 receptor blocking agents, or proton pump inhibitors (PPIs), and have failed attempts for endoscopic intervention to control the bleeding] [5]. Embolic agents in TAE can be either coil, gelatin sponge, polyvinyl alcohol (PVA), N-butyl 2-cyanoacrylate (NBCA) glue, or ethylene-vinyl alcohol copolymer [6]. The use of coils and micro coils had shown lower infarction rates, and studies had shown better results when coils were used with any of the above-mentioned embolic agents, especially PVA and gelatin sponge in patients with coagulopathies [6]. Our patient also underwent a similar procedure due to underlying coagulopathy. Coils are used in a very precise fashion and carry a low risk of infarction secondary to preserving the distal microvasculature because of their size and length ratio to the vasculature [2]. Use of NBCA embolotherapy (NBCA) and a gelatin sponge alone is safe except for increased chances of rebleeds with using just a gelatin sponge which is a cheaper option [7]. The outcome of doing TAE depends upon the etiology of the bleed. Prophylactic TAE has more chances of rebleeds than therapeutic ones [8]. Overall complications after getting a TAE range from groin hematomas to contrast-induced nephropathy (CIN). The outcome of embolization in upper gastrointestinal bleeds has been reportedly better than the lower gastrointestinal bleeds due to a better collateral supply of vessels [2].
Conclusions
Transcatheter arterial embolization as an alternative to endoscopic intervention for rapid gastrointestinal bleeding has been previously used as a therapeutic tool. However, it is considered more invasive than endoscopy. Although endoscopic interventions can control most bleeding ulcers, angiographic embolization can be successfully performed if endoscopic methods fail. Therefore, angiographic embolization in the setting of hematochezia or arterial bleed may be considered initially to minimize the time to therapeutic intervention. Further comparative data are required to make definitive conclusions as randomized control trials are lacking in this regard.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study
References
- 1.Incidence of duodenal ulcers and gastric ulcers in a Western population: back to where it started. Groenen MJ, Kuipers EJ, Hansen BE, Ouwendijk RJ. Can J Gastroenterol. 2009;23:604–608. doi: 10.1155/2009/181059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Transcatheter arterial embolization for acute nonvariceal upper gastrointestinal bleeding: Indications, techniques and outcomes. Loffroy R, Favelier S, Pottecher P, et al. Diagn Interv Imaging. 2015;96:731–744. doi: 10.1016/j.diii.2015.05.002. [DOI] [PubMed] [Google Scholar]
- 3.Emergency transcatheter arterial embolization for patients with acute massive duodenal ulcer hemorrhage. Wang YL, Cheng YS, Liu LZ, He ZH, Ding KH. World J Gastroenterol. 2012;18:4765–4770. doi: 10.3748/wjg.v18.i34.4765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gastrodoudenal embolization: indications, technical pearls, and outcomes. Kuyumcu G, Latich I, Hardman RL, Fine GC, Oklu R, Quencer KB. J Clin Med. 2018;7:101. doi: 10.3390/jcm7050101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Loffroy R, Guiu B, D'Athis P, et al. Clin Gastroenterol Hepatol. 2009;7:515–523. doi: 10.1016/j.cgh.2009.02.003. [DOI] [PubMed] [Google Scholar]
- 6.Transcatheter arterial embolization for upper gastrointestinal tract bleeding. Širvinskas A, Smolskas E, Mikelis K, Brimienė V, Brimas G. Wideochir Inne Tech Maloinwazyjne. 2017;12:385–393. doi: 10.5114/wiitm.2017.72319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Transcatheter arterial embolization of gastrointestinal bleeding with N-butyl cyanoacrylate: a systematic review and meta-analysis of safety and efficacy. Kim PH, Tsauo J, Shin JH, Yun SC. J Vasc Interv Radiol. 2017;28:522–531. doi: 10.1016/j.jvir.2016.12.1220. [DOI] [PubMed] [Google Scholar]
- 8.Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy. Sildiroglu O, Muasher J, Arslan B, et al. J Clin Gastroenterol. 2014;48:687–692. doi: 10.1097/MCG.0000000000000181. [DOI] [PubMed] [Google Scholar]


